abstract |
The present invention relates to compositions and their use. The present invention relates to compositions for use in stimulating new antigen production in cancerous tumors. In particular, the composition comprises a compound or a pharmaceutically acceptable salt thereof, which is a negative modulator of expression, function or stability of ribonucleotide reductase. [Selection diagram] Fig. 1 |